Bioventix PLC (LON:BVXP)’s share price traded down 2.8% during trading on Tuesday . The company traded as low as GBX 3,150 ($41.16) and last traded at GBX 3,160 ($41.29), 2,907 shares changed hands during trading. A decline of 47% from the average session volume of 5,505 shares. The stock had previously closed at GBX 3,250 ($42.47).
Separately, FinnCap upped their price objective on Bioventix from GBX 3,700 ($48.35) to GBX 3,750 ($49.00) and gave the company a “corporate” rating in a research report on Monday, October 21st.
The company has a market cap of $167.29 million and a PE ratio of 28.19. The business has a 50-day moving average of GBX 3,393.70 and a 200 day moving average of GBX 3,704.02.
In other Bioventix news, insider Ian James Nicholson sold 2,500 shares of the company’s stock in a transaction dated Friday, October 25th. The stock was sold at an average price of GBX 3,159 ($41.28), for a total value of £78,975 ($103,194.83).
About Bioventix (LON:BVXP)
Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications.
Featured Story: What is the role of the G-20?
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.